Repithel

08/01/2006 - "The time until wounds were closed completely was significantly shorter in patients receiving Repithel than in controls. "
01/01/2004 - "[Repithel: the future of wound management]."
08/01/2006 - "The positive effects of Repithel on wound healing were especially observed in smokers, patients with chronic wounds, burns or infected wounds. "
08/01/2006 - "Wounds receiving Repithel showed a significantly faster neoepithelisation than wounds which were treated with lipid gauze alone. "
09/01/2006 - "Grafts of 167 patients (donor site defects, burn wounds, or chronic defects) were dressed either with Repithel (n=83) covered with a gauze (Jelonet), or Jelonet-gauze only (n=84) until healing. "

08/01/2006 - "The positive effects of Repithel on wound healing were especially observed in smokers, patients with chronic wounds, burns or infected wounds. "
09/01/2006 - "Grafts of 167 patients (donor site defects, burn wounds, or chronic defects) were dressed either with Repithel (n=83) covered with a gauze (Jelonet), or Jelonet-gauze only (n=84) until healing. "
09/01/2008 - "A liposomal hydrogel with 3% povidone-iodine (PVP-ILH, Repithel) has shown clinical benefit in settings where inflammation and/or reactive oxygen species are thought to impede wound healing (e.g., burns, chronic wounds and in smokers). "

09/01/2008 - "A liposomal hydrogel with 3% povidone-iodine (PVP-ILH, Repithel) has shown clinical benefit in settings where inflammation and/or reactive oxygen species are thought to impede wound healing (e.g., burns, chronic wounds and in smokers). "

01/01/2006 - "All tested concentrations of povidone- iodine formulations (5-10% Repithel, 2.5-5% Betaisodona ointment and 1.25-2.5% Betaisodona solution) are not genotoxic in the chromosome aberration test. "
01/01/2006 - "10% Repithel, 5% Betaisodona ointment and 2.5% Betaisodona solution in culture medium with 10% fetal bovine serum were final concentrations in the chromosome aberration test, which provide <60% cytotoxicity within 4 h of contact with CHO-K1 cells. "